# FDA Inspection 1198013 - AbbVie Inc. - January 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/abbvie-inc/54654ce6-6050-43ed-a173-2eff6517407c
Source feed: FDA_Inspections

> FDA Inspection 1198013 for AbbVie Inc. on January 31, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198013
- Company Name: AbbVie Inc.
- Inspection Date: 2023-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299008 - 2026-04-27](https://www.keypedia.com/records/fda_inspections/abbvie-inc/64d362ca-4924-4cf2-8bc0-85ea4d863db0)
- [FDA Inspection 1302298 - 2026-04-02](https://www.keypedia.com/records/fda_inspections/abbvie-inc/00651199-0676-4364-ac4b-a2e38a34895a)
- [FDA Inspection 1277010 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d998b409-04ec-4d4c-8b31-fbb0807bde69)
- [FDA Inspection 1277010 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/20aba2c4-bf11-4f96-ab4a-2bff02a0efb6)
- [FDA Inspection 1257605 - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/48e53750-1fe1-4280-8d26-fdff5c926853)

Company: https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c